1034 related articles for article (PubMed ID: 25679172)
1. Impact of dose calculation accuracy during optimization on lung IMRT plan quality.
Li Y; Rodrigues A; Li T; Yuan L; Yin FF; Wu QJ
J Appl Clin Med Phys; 2015 Jan; 16(1):5137. PubMed ID: 25679172
[TBL] [Abstract][Full Text] [Related]
2. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
4. Robust optimization in lung treatment plans accounting for geometric uncertainty.
Zhang X; Rong Y; Morrill S; Fang J; Narayanasamy G; Galhardo E; Maraboyina S; Croft C; Xia F; Penagaricano J
J Appl Clin Med Phys; 2018 May; 19(3):19-26. PubMed ID: 29524301
[TBL] [Abstract][Full Text] [Related]
5. Comparison of direct machine parameter optimization versus fluence optimization with sequential sequencing in IMRT of hypopharyngeal carcinoma.
Dobler B; Pohl F; Bogner L; Koelbl O
Radiat Oncol; 2007 Sep; 2():33. PubMed ID: 17822529
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
[TBL] [Abstract][Full Text] [Related]
7. Potential for reduced radiation-induced toxicity using intensity-modulated arc therapy for whole-brain radiotherapy with hippocampal sparing.
Pokhrel D; Sood S; Lominska C; Kumar P; Badkul R; Jiang H; Wang F
J Appl Clin Med Phys; 2015 Sep; 16(5):131–141. PubMed ID: 26699321
[TBL] [Abstract][Full Text] [Related]
8. A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse.
Peters S; Schiefer H; Plasswilm L
Radiat Oncol; 2014 Jul; 9():153. PubMed ID: 25011529
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of two treatment planning systems for spine SBRT.
Lee YK; Munawar I; Mashouf S; Sahgal A; Ruschin M
Med Dosim; 2020 Spring; 45(1):77-84. PubMed ID: 31376988
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated stereotactic radiotherapy for brain metastases: a dosimetric and treatment efficiency comparison between volumetric modulated arc therapy and intensity modulated radiotherapy.
Ma Y; Li M; Yin Y; Kong L; Sun X; Lin X; Yu J
Technol Cancer Res Treat; 2010 Oct; 9(5):499-507. PubMed ID: 20815421
[TBL] [Abstract][Full Text] [Related]
11. Inverse-planned deliverable 4D-IMRT for lung SBRT.
Hamzeei M; Modiri A; Kazemzadeh N; Hagan A; Sawant A
Med Phys; 2018 Nov; 45(11):5145-5160. PubMed ID: 30153339
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of OAR dose sparing and plan robustness of beam-specific PTV in lung cancer IMRT treatment.
Chang Y; Xiao F; Quan H; Yang Z
Radiat Oncol; 2020 Oct; 15(1):241. PubMed ID: 33069253
[TBL] [Abstract][Full Text] [Related]
13. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
14. A dosimetric comparison of intensity-modulated radiotherapy versus rapid arc in gynecological malignancies: Dose beyond planning target volume, precisely 5Gy volume.
Sidhu MS; Singh K; Sood S; Aggarwal R
J Cancer Res Ther; 2023; 19(5):1267-1271. PubMed ID: 37787294
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric impact of intermediate dose calculation for optimization convergence error.
Park BD; Kim TG; Kim JE
Oncotarget; 2016 Jun; 7(25):37589-37598. PubMed ID: 26933998
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
17. Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.
Lu JY; Wu LL; Zhang JY; Zheng J; Cheung ML; Ma CC; Xie LX; Huang BT
Br J Radiol; 2015 Feb; 88(1046):20140654. PubMed ID: 25494885
[TBL] [Abstract][Full Text] [Related]
18. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]